-+ 0.00%
-+ 0.00%
-+ 0.00%

Revvity releases transcript of Q2 2026 earnings call

PUBT·08/05/2026 23:04:04
Listen to the news
Revvity releases transcript of Q2 2026 earnings call
  • Revvity’s Q2 2026 earnings call drew CEO Prahlad R. Singh, CFO Maxwell Krakowiak, IR head Stephen Barr Willoughby, analysts.
  • Raised 2026 pro forma organic growth outlook to 4%-5%; pro forma revenue seen at USD 2.83 billion-USD 2.86 billion.
  • Lifted pro forma adjusted EPS view to USD 5.30-USD 5.40; pro forma adjusted operating margin target moved to 28.7%.
  • Q2 revenue USD 711 million; pro forma organic growth 3%; adjusted EPS USD 1.41, helped by USD 16 million tariff refunds.
  • Signed definitive agreement to divest China immunodiagnostics business; closing expected by end-2027; management cited rising AI-driven instrument demand and backlog.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revvity Inc. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.